OneMedNet Corp. Reports Director and Officer Changes

Ticker: ONMDW · Form: 8-K · Filed: Feb 6, 2025 · CIK: 1849380

Onemednet CORP 8-K Filing Summary
FieldDetail
CompanyOnemednet CORP (ONMDW)
Form Type8-K
Filed DateFeb 6, 2025
Risk Levelmedium
Pages2
Reading Time2 min
Key Dollar Amounts$0.0001, $11.50, $25,000
Sentimentneutral

Sentiment: neutral

Topics: leadership-change, executive-compensation, governance

Related Tickers: ONMD

TL;DR

Board shakeup and comp changes at OneMedNet. New directors in, some execs out.

AI Summary

OneMedNet Corp. announced on January 31, 2025, changes related to its board of directors and executive compensation. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key personnel. This report follows the company's transition from its former name, Data Knights Acquisition Corp., on March 4, 2021.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence.

Risk Assessment

Risk Level: medium — Changes in leadership and compensation structures can introduce uncertainty regarding future strategy and performance.

Key Players & Entities

FAQ

What specific roles have been affected by the departure of officers or directors?

The filing indicates the departure of certain officers and directors, but does not specify the exact roles vacated in this summary.

Who are the newly elected directors?

The filing mentions the election of directors but does not name the individuals in the provided text.

What are the details of the compensatory arrangements for certain officers?

The filing states that there are adjustments to compensatory arrangements for certain officers, but the specific details are not included in this summary.

When did OneMedNet Corporation officially change its name?

OneMedNet Corporation officially changed its name from Data Knights Acquisition Corp. on March 4, 2021.

What is the primary business of OneMedNet Corp. according to the filing?

OneMedNet Corp. is classified under SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731].

Filing Stats: 500 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2025-02-06 17:04:55

Key Financial Figures

Filing Documents

From the Filing

UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 31, 2025 ONEMEDNET CORPORATION (Exact name of registrant as specified in its charter) Delaware 001-40386 86-2076743 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 6385 Old Shady Oak Road , Suite 250 Eden Prairie , MN 55344 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: 800 - 918-7189 Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.0001 par value per share ONMD The Nasdaq Stock Market LLC Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share ONMDW The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. As previously disclosed in a Current Report on Form 8-K filed on August 30, 2024 (the "Prior Report"), the board of directors (the "Board") of OneMedNet Corporation (the "Company") appointed Robert Golden to serve as Chief Financial Officer ("CFO") on an interim basis. On January 31, 2025, the Board appointed Mr. Golden as CFO of the Company on a permanent basis. In connection with his permanent appointment as CFO, in addition other amounts previously reported, Mr. Golden will also receive a cash bonus of $25,000 and a grant of restricted stock units equal to $25,000, which will be fully vested on the grant date. The disclosure in the Prior Report regarding Mr. Golden is incorporated by reference in this filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: February 6, 2025 ONEMEDNET CORPORATION By: /s/ Aaron Green Aaron Green Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing